Videos

Search for:
to
x clear all filters
Featured image
calanderBy Prof. Sven Francque
calander9 June 2022
5Th Global Nash Congress
Featured image
calanderBy Prof. A.G.(Onno) Holleboom
calander25 May 2022
Going beyond the liver in NAFLD/NASH: hepatologist’s / endocrinologist’s perspective
Featured image
calanderBy Prof. A.G.(Onno) Holleboom
calander9 May 2022
Getting to the heart of NAFLD/NASH – the CVD perspective
Featured image
calanderBy Prof. Jérôme Boursier
calander22 April 2022
Non-Invasive Evaluation of NAFLD Severity
Featured image
calanderBy Dr Romero-Gomez
calander12 April 2022
NIT for screening, referral & diagnosis of NAFLD
Featured image
calanderBy Dr. Maarten E. Tushuizen
calander4 April 2022
NAFLD/NASH as a metabolic disease: improving patients outcomes
Featured image
calanderBy Prof. Stéfan Darmoni
calander23 March 2022
Clinical Data Warehouse : definitions and use cases
Featured image
calanderBy Prof. A.G.(Onno) Holleboom
calander16 March 2022
NAFLD / NASH as a metabolic disease: improving patients outcomes
Featured image
calanderBy Prof. François Dufour
calander10 March 2022
Cancers and NASH
Featured image
calanderBy Prof. Marat Fudim
calander24 February 2022
Link between NAFLD and HFpEF
Featured image
calanderBy Dr. Nicolas Lanthier
calander24 January 2022
Interactions between gut microbiota and PPARs in NAFLD
Featured image
calanderBy Prof. Zelber-Sagi
calander10 January 2022
Lifestyle treatment for NAFLD in daily practice
Featured image
calanderBy Prof. Robert Chilton
calander31 December 2021
NASH and CV disease: new considerations
Featured image
calanderBy Dr. Moritz Peiseler
calander22 December 2021
New insights into the role of inflammation in NAFLD
Featured image
calanderBy Prof. Zelber-Sagi
calander25 November 2021
Lifestyle prevention & treatment for NAFLD
Featured image
calanderBy Prof. Rautou
calander16 November 2021
Liver sinusoidal endothelial cell (LSEC) capillarization in NASH
Featured image
calanderBy Dr Romero-Gomez
calander25 October 2021
The course of liver histology and morbi-mortality in NAFLD / NASH
Featured image
calanderBy Dr Wong and Dr Cusi
calander11 October 2021
The complex interaction between body weight and NAFLD / NASH
Featured image
calanderBy Prof. Jeffrey V Lazarus
calander28 September 2021
Defining comprehensive models of care for NAFLD Liver health specialists
Featured image
calanderBy Prof. Bugianesi
calander9 August 2021
HCC in Patients with NAFLD/NASH
Featured image
calanderBy Prof. Schattenberg
calander27 July 2021
NASH and quality of life
Featured image
calanderBy Prof. Sanyal
calander15 July 2021
NASH is part of a multi-system disorder
Featured image
calanderBy Prof. Sven Francque
calander6 July 2021
From number-one liver disease to multi-system disease: NASH, a major unmet clinical need
Featured image
calanderBy Dr Romero
calander16 June 2021
Imaging biomarkers in NAFLD: Could they avoid liver biopsy
Featured image
calanderBy Prof. F. Tacke
calander10 June 2021
Inflammation in NASH and the transition to HCC: an update on scientific breakthroughs by Dr Peiseler and Prof Tacke, Germany
Featured image
calanderBy Prof. F. Tacke
calander31 May 2021
New insights into liver macrophages in NASH pathogenesis
Featured image
calanderBy Dr. Byrne
calander31 May 2021
Non-alcoholic fatty liver disease (NAFLD): a multisystem disease – part 2
Featured image
calanderBy Dr. Byrne
calander11 May 2021
Non-alcoholic fatty liver disease (NAFLD): a multisystem disease – part 1
Featured image
calanderBy Prof. Kenneth Cusi
calander4 May 2021
Management of non-alcoholic steatohepatitis (NASH): a multiorgan disease driven by insulin resistance, obesity and T2D
Featured image
calanderBy Prof. Sanyal
calander16 April 2021
Phase 3 development in the field of non-alcoholic steatohepatitis (NASH)
Featured image
calanderBy Prof. Magdy Abdelhamid
calander15 April 2021
NASH treatment: State of the art in 2020
Featured image
calanderBy Prof. Kenneth Cusi
calander22 March 2021
Management of Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: Weight gain with PPAR-γ Agonists
Featured image
calanderBy Prof. Kenneth Cusi
calander8 March 2021
Management of patients with T2D and NAFLD: the role of PPAR-γ
Featured image
calanderBy Prof. Sven Francque
calander19 February 2021
Nonalcoholic steatohepatitis: the role of PPARs (Peroxisome proliferator-activated receptors)
Featured image
calanderBy Prof. Kenneth Cusi
calander1 February 2021
Management of patients with Type 2 Diabetes (T2DM) and Nonalcoholic Fatty Liver Disease (NAFLD)
Featured image
calanderBy Prof. Sacks
calander1 December 2020
PPAR gamma agonist
Featured image
calanderBy Prof. Rautou
calander26 November 2020
Biomarkers in NASH
Featured image
calanderBy Prof. Roden
calander11 November 2020
PPAR’s as critical regulators of metabolism
Featured image
calanderBy Prof. Sacks
calander14 October 2020
PPAR alpha delta : what you need to know about the latest results
Featured image
calanderBy Prof. Sacks
calander8 October 2020
PPAR alpha gamma dual agonists : what you need to know
Featured image
calanderBy Prof. G Rosano
calander10 September 2020
The prevalence, risks and costs of NASH
Featured image
calanderBy Prof. Roden
calander22 September 2020
NAFLD and states of insulin resistance
Featured image
calanderBy Prof. Sacks
calander3 September 2020
Lipids effects of PPARs by Prof. F. Sacks
Featured image
calanderBy Prof. Rautou
calander28 August 2020
Microvesicles as NAFLD biomarkers: a clinician’s point of view by Prof. P. E. Rautou
Featured image
calanderBy Prof. Sacks
calander5 August 2020
The link between lipids and PPARs in NASH by Prof. F. Sacks
Featured image
calanderBy Prof. P. Bedossa
calander22 July 2020
Liver biopsy in NASH by Prof. P. Bedossa
Featured image
calanderBy Prof. F. Tacke
calander25 June 2020
The multiple risks in NAFLD by Prof. F. Tacke
Featured image
calanderBy Prof. P. Bedossa
calander10 June 2020
Liver biopsy in NASH clinical trials by Prof. P. Bedossa
Featured image
calanderBy Prof. F. Tacke
calander27 May 2020
Role of PPARs (experimental paper) by Prof. F. Tacke
Featured image
calanderBy Prof. Sven Francque
calander21 May 2020
NAFLD: time to update the terminology? By Prof. S. Francque
Featured image
calanderBy Prof. Sven Francque
calander12 May 2020
NASH and NAFL: it is not only about liver but it is a complex inter-organ crosstalk in which adipose tissue dysfunction is an important driver of the disease.
Featured image
calanderBy Prof. Sven Francque
calander6 May 2020
NAFLD: a hegemonic disease by Prof. S. Francque
Featured image
calanderBy Prof. Dufour
calander24 April 2020
PPARs: State-of-the-art by Prof. J.-F. Dufour
Featured image
calanderBy Prof. Sven Francque
calander16 April 2020
The role of a global holistic approach in NASH management: important messages
Featured image
calanderBy Prof. Kenneth Cusi
calander8 April 2020
The role of insulin resistance and insulin-sensitizers in NASH management: tips for the practicing clinician
Featured image
calanderBy Prof. Dufour
calander2 April 2020
The role of comorbidities in NASH management: a holistic approach
Featured image
calanderBy Prof. Rautou
calander25 March 2020
The role of liver sinusoidal endothelial cells
Featured image
calanderBy Prof. Magdy Abdelhamid
calander19 March 2020
What can we expect from PPAR agonists in the treatment of NASH?
Featured image
calanderBy Prof. Sancho
calander11 March 2020
Pre-clinical study with Lanifibranor – Prof Gracia-Sancho
Featured image
calanderBy Prof. Roden
calander26 February 2020
The role of PPARs in NASH fibrogenesis
Featured image
calanderBy Prof. Szabo
calander12 February 2020
The role of PPARs in NASH fibrogenesis
Featured image
calanderBy Prof. F. Tacke
calander5 February 2020
The role of PPARs in inflammation
Featured image
calanderBy Prof. Sven Francque
calander24 January 2020
Important trials during the Liver meeting in Boston
Featured image
calanderBy Prof. Sancho
calander20 January 2020
Prof Jordi Gracia-Sancho, Barcelona, discusses the need to develop new therapeutic approaches that target more than one molecular pathway for chronic liver disease.
Featured image
calanderBy Prof. Roden
calander9 January 2020
Prof Roden highlights the sessions dedicated to obesity and the metabolic syndrom held during the Liver meeting 2019 in Boston
Featured image
calanderBy Prof. Dufour
calander9 December 2019
Prof Jean-François Dufour highlights why the Liver meeting 2019 in Boston is relevant for NASH investigators with presentations of new modes of action and non-invasive biomarkers.
Featured image
calanderBy Prof. Szabo
calander5 December 2019
Prof G. Szabo reviews the learnings about alcohol consumption and liver disease that were presented during the Liver meeting 2019 in Boston.
Featured image
calanderBy Prof. F. Tacke
calander29 November 2019
Prof Tacke explains why he feels the basic science part of the Liver meeting 2019 in Boston was exciting.
Featured image
calanderBy Prof. Kenneth Cusi
calander25 November 2019
Prof Cusi sheds light on the new exciting information made public at the Liver meeting in Boston
Featured image
calanderBy Prof. Magdy Abdelhamid
calander25 November 2019
Prof Abdelmalek shares her perspectives about the highlights of the Liver meeting in Boston. She sees a lot of hope in new clinical trials and new biomarkers.
Featured image
calanderBy Prof. Sancho
calander18 November 2019
Prof Jordi Gracia-Sancho, Barcelona, discusses this important topic in an interview filmed in Boston during the Liver meeting 2019.
Featured image
calanderBy Prof. Dufour
calander1 November 2019
Prof Dufour discusses best practices about the diagnosis of NASH
Featured image
calanderBy Prof. Kenneth Cusi
calander13 September 2019
Prof Kenneth Cusi, USA discusses the role of diabetologists in screening for NASH
Featured image
calanderBy Prof. Sven Francque
calander23 July 2019
Why are PPAR agonists a promising option for the management of NASH ?
Featured image
calanderBy Prof. Kenneth Cusi
calander3 July 2019
Lipotoxicity in NASH
Featured image
calanderBy Prof. Szabo
calander24 June 2019
Prof Szabo, USA discusses the progresses of the quest of biomarkers in NASH
Featured image
calanderBy Prof. Magdy Abdelhamid
calander10 May 2019
An insight into the prevalence of NAFLD and NASH. Prof Abdelmalek, USA
Featured image
calanderBy Prof. Magdy Abdelhamid
calander10 May 2019
What are the current definitions ? Prof Abdelmalek, USA
Featured image
calanderBy Prof. Sven Francque
calander10 May 2019
Learn more about the burden of the disease, Prof Sven Francque, Belgium
Featured image
calanderBy Prof. Dufour
calander9 May 2019
Is NASH only about the liver ?
Featured image
calanderBy Prof. Rautou
calander16 June 2016
Prof Pierre-Emmanuel Rautou, Paris, France highlights two important abstracts